UPDATE: Goldman Sachs Raises PT on Accretive Health to $21 (AH)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Goldman Sachs is out with its report today on Accretive Health (NYSE: AH), raising its PT from $14 to $21.In a note to clients, Goldman Sachs states, "We increase our 12 month price target to $21 from $14, which is based on a blend of our EV/EBITDA (50%), PEG (30%), and DCF (20%) valuation analyses. Our price target rises given we roll forward to 2012E estimates (from 2011E) and assume greater long-term EBITDA margin expansion."Goldman Sachs maintains Neutral on AH.Shares of AH closed Wednesday at $20.00.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!